Clinical trial
Ezetimibe and Simvastatin in Dyslipidemia of Diabetes
NCT00157482 · Mario Negri Institute for Pharmacological Research, Other · Completed
Key facts
| NCT number | NCT00157482 |
|---|---|
| Title | Ezetimibe and Simvastatin in Dyslipidemia of Diabetes |
| Official title | A Randomized, Prospective, Double-Blind Study to Evaluate the Effects on Lipid Profile of Combined Ezetimibe and Simvastatin Therapy as Compared to Simvastatin Alone in People With Type 2 Diabetes |
| Lead sponsor | Mario Negri Institute for Pharmacological Research, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Ezetimibe, Simvastatin |
| Enrollment | 108 |
| Start date | Jan 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 13, 2007 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: